What is the 52 Week High and Low of Caplin Point Laboratories Share Price?

The 52 week high and low prices of Caplin Point Laboratories share price is 2409 & 1500.3. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Caplin Point Laboratories Share price

Q: How to buy Caplin Point Laboratories Share at Choice?

To buy Caplin Point Laboratories stocks , log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Caplin Point Laboratories, choose your preferred order type, and place the trade.

CAPLIPOINT

Healthcare Large Cap

2309.4

54.20 (2.40%)

NSE

BSE

Last updated on 10 Jun, 2026 | 15:45 IST

BuySell

Today's High

2409.00

Today's Low

2240.40

52 Week Low

1500.30

52 Week High

2409.00

Caplin Point Laboratories Chart

ChartIQ

TradingView

Caplin Point Laboratories Share Key Metrics

Volume

8.62 L

Market Cap

17554.14 CR

LTQ@LTP

50@2309.40

ATP

2363.9

Var Margin

18.47 %

Circuit Range

1804.2-2706.2

Delivery %

24.17 %

Value

203.66 CR

ASM/GSM

No

Market Lot

1

Summary

Caplin Point Laboratories share price is ₹2309.4 as of 11 Jun, 2026. The stock Caplin Point Laboratories intraday movement has stayed between ₹2240.40 and ₹2409.00, while on a 52-week basis,Caplin Point Laboratories price 52 week high is ₹2409.00 & its 52 week low is ₹1500.30.

In terms of trading activity, Caplin Point Laboratories has recorded a volume of 861544 shares, The Caplin Point Laboratories has a market cap of ₹76011696 CR. The stock’s Average Traded Price (ATP) stands at ₹2363.90, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 50 @ ₹2309.40.

Caplin Point Laboratories operates within a circuit range of ₹1804.20 – ₹2706.20, with a Value of ₹203.66 CR. The Delivery Percentage for the day is 24.17%. Additionally, Caplin Point Laboratories currently falls under the No framework, and trades with a market lot size of 1.

Caplin Point Laboratories Fundamentals

P/E Ratio

26.76

P/B Ratio

4.78

Div. Yield

0.18

Sector P/E

70.43

Sector P/B

3.01

Sec. Div. Yield

0.54

Caplin Point Laboratories Resistance and Support

Pivot 2220.83

Resistance

First Resistance

2320.36

Second Resistance

2385.53

Third Resistance

2485.06

Support

First Support

2155.66

Second Support

2056.13

Third Support

1990.96

Caplin Point Laboratories Shareholding Pattern

2016-17
2018-19
2019-20
2020-21
2021-22
2022-23
2023-24
2024-25
2025-26
2026-27

Total Promoters

Segment

Percent

Total Promoters

70.56%

Mutual Fund

1.86%

Insurance

0.14%

Foreign Institutional Investors

4.86%

Domestic Institutional Investors

0.11%

Retail

22.47%

Others

0%

Total Promoters

MAR '24

70.62%

JUN '24

70.56%

SEP '24

70.56%

DEC '24

70.56%

Caplin Point Laboratories Corporate Actions

Date	Agenda
2026-05-14	Audited Results & Interim Dividend
2026-02-05	Quarterly Results
2025-11-06	Quarterly Results
2025-11-05	Quarterly Results
2025-08-07	Quarterly Results
2025-05-15	Audited Results & Interim Dividend
2025-02-07	Quarterly Results

Caplin Point Laboratories News

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

Caplin Point Laboratories will attend the 16th Annual Global Investor Conference, 'TRINITY INDIA 2026', on May 28, 2026, in Mumbai. The company will engage with various analysts and institutional investors through one-on-one and group meetings.

May 22 2026 18:18:38

Caplin Point Laboratories Ltd - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Caplin Point Laboratories' subsidiary, Caplin Steriles Limited, secured USFDA final approval for Foscarnet Sodium Injection (6000 mg/250 mL), a generic antiviral drug. This approval opens up access to the US market for a product with approximately $15 million in annual sales.

May 14 2026 19:00:12

Caplin Point Laboratories Ltd - 524742 - Corporate Action-Board approves Dividend

Caplin Point declared an interim dividend of ₹4.00 per equity share (200% on ₹2 face value) for FY26. The record date for eligibility is May 30, 2026, impacting shareholders for the fiscal year ending March 31, 2026.

May 14 2026 13:28:25

Caplin Point Laboratories Ltd - 524742 - Board Meeting Outcome for For Meeting Held On May 14, 2026

Caplin Point Laboratories board declared an interim dividend of ₹4.00 per share and approved Q4 and FY26 consolidated results. For Q4 FY26, total revenue rose 19% YoY to ₹628.52 cr, and net profit increased 19% YoY to ₹172.88 cr. The full-year FY26 saw total revenue grow 13.2% YoY to ₹2,302.73 cr and net profit rise 20.1% YoY to ₹649.73 cr, with a record date for dividend set for May 30, 2026.

May 14 2026 13:16:43

Name	Position
G Venkatram	General Counsel & Company Secretary, Compliance Officer
C C Paarthipan	Chairman

Caplin Point Laboratories Similar Stocks

Onesource Specialty Pharma Ltd.

1699.60

-15.80 (0.92%)

Granules India Ltd.

760.80

-4.25 (0.56%)

Eris Lifesciences Ltd.

1366.90

-6.80 (0.50%)

Astrazeneca Pharma India Ltd.

8288.50

-164.50 (1.95%)

Cohance Lifesciences Ltd.

430.50

-1.40 (0.32%)

Natco Pharma Ltd.

854.60

-10.40 (1.20%)

Jubilant Pharmova Ltd.

964.45

-7.50 (0.77%)

Alembic Pharmaceuticals Ltd.

737.20

5.70 (0.78%)

Dr. Agarwal's Health Care Ltd.

449.00

0.50 (0.11%)

Poly Medicure Ltd.

1417.50

-41.30 (2.83%)

Caplin Point Laboratories FAQs

The Buying Price of Caplin Point Laboratories share is 2309.4 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Caplin Point Laboratories stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Caplin Point Laboratories, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Caplin Point Laboratories shares is 26.76. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Caplin Point Laboratories shares is 4.78. Useful to assess the stock's value relative to its book value.

To assess Caplin Point Laboratories’s valuation compare Sector P/E, P/B which are 70.43 & 3.01 with sector averages, along with growth rates and financial metrics.

The Market Cap of Caplin Point Laboratories is 17554.14 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Caplin Point Laboratories share price is 2409.00 & 1500.30. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Caplin Point Laboratories belongs to the Healthcare sector.